Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 20,275 ACRV shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 20,275 | n/a |
| Jun 12, 2026 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 77,000 | n/a |
| May 20, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 9,366 | n/a |
| Jun 17, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 20,275 | n/a |
| Jun 12, 2025 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 40,000 | n/a |
| Aug 29, 2024 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 40,000 | n/a |
| Jun 24, 2024 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 20,275 | n/a |
| Jun 9, 2023 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 30,000 | n/a |
| Nov 17, 2022 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 35,235 | n/a |
| Oct 21, 2022 | Milestone Pharmaceuticals Inc. (MIST) | Purchase | 15,000 | $79.8K |